Sou Hu Cai Jing·2025-06-06 19:53Core Viewpoint - Fosun Pharma's stock price has experienced a slight decline, with a current market capitalization of 66.841 billion yuan, ranking 6th in the chemical pharmaceutical sector and 207th in the A-share market [1] Company Announcements - As of May 31, 2025, Fosun Pharma has repurchased a total of 7,310,552 A-shares, accounting for 0.2738% of the total share capital, with a total repurchase amount of approximately 174.98 million yuan [2][6] - The company has also completed the repurchase and cancellation of 897,140 restricted A-shares, reducing the total share capital from 2,671,326,465 shares to 2,670,429,325 shares, and the registered capital from 2,671,326,465 yuan to 2,670,429,325 yuan [3][5][6] - A new employee director, Ms. Yan Jia, has been elected to the 10th Board of Directors, pending approval of related proposals at the upcoming shareholders' meeting [4][6]